November 12, 1991 |
A year and a half ago, diabetic Cyndie Flores of Garden Grove was losing ground fast, and she knew it. The red blood vessels in her eyes "looked like they were going to rupture," a warning sign of diabetic retinopathy, the leading cause of blindness in people ages 20 to 74. Her feet tingled with the sensation of pins and needles, a signal that nerve damage was beginning to take place in her extremities.
June 7, 2000 |
Canadian researchers have successfully freed eight diabetics from insulin dependence by using a new combination of anti-rejection drugs to transplant insulin-secreting islet cells. All of the subjects have remained insulin-free for four to 15 months, a remarkable rate, because fewer than one in 10 patients who received islet transplants previously were able to escape their daily shots. "This is perhaps the most important finding in Type 1 diabetes research in the past decade," said Dr.
September 17, 2008 |
Valencia biotechnology company MannKind Corp. thought it had encouraging news about its experimental insulin inhaler on Tuesday. But Wall Street wasn't buying it. For months, skeptical traders have expressed concern that the diabetes drug, if approved by the Food and Drug Administration, might end up with an FDA cancer advisory. Fears that the inhaler would never take off were still lurking Tuesday, even though MannKind said that trials of its Technosphere insulin delivery system showed no elevated cancer risk.
June 17, 2011 |
Jamie Powers has Type 2 diabetes. He weighs about 370 pounds and is in a wheelchair because complications from his disease required that his left leg be amputated below the knee. He takes daily pills and insulin shots. I met Powers, 55, earlier this week at a hotel near Los Angeles International Airport, where he was among about 200 people attending a seminar titled "Diabetes Breakthrough. " A newspaper ad promised that "you will discover the hidden secrets about how to reverse your diabetes, reduce and eliminate your need and dependence on drugs, lose weight without exercise, explode your energy levels and the potential to become non-diabetic.
September 30, 1990 |
In 1922, Urvan Ubben's parents had his "funeral picture" taken, certain he would be the next family member to die of diabetes. Today, the 77-year-old laughs at the childhood photo and how he cheated death by being one of the first people to test insulin. Experts say he may be the world's oldest surviving diabetic. "I was one of the guinea pigs when Eli Lilly was trying to mass-produce insulin in Indianapolis back in 1922," Ubben said. "In those days, they figured that if you had diabetes, you didn't have a chance.
September 22, 2010
The basics In the simplest terms, diabetes means having too much glucose in your blood. Glucose is a type of sugar and a source of energy for the body. But if insulin, glucose’s “traffic cop,” isn’t doing its job, glucose accumulates in the bloodstream and all sorts of health problems can occur. Normally, most of the food a person eats gets converted into glucose, the body’s energy of choice. The circulatory system shuttles the glucose around so that hungry cells in the muscles, liver and elsewhere can snatch it out of the blood as it passes by. The liver cells are the hungriest for that glucose, because the liver is the body’s between-meal glucose storage facility.
CALIFORNIA | LOCAL
July 17, 1989 |
Diabetics given a new pancreas to eliminate the need for insulin shots may also end up with healthier kidneys, six Minneapolis doctors reported last week in the New England Journal of Medicine. The discovery supports a long-held belief that if diabetics could carefully control their blood-sugar level, they might be able to avoid the kidney failure, blindness and other serious health problems that appear in many longtime sufferers of the disease.
October 26, 2009 |
Simply put, diabetes is a contest between people and their blood. For people whose bodies don't produce enough insulin to manage their blood sugar, the goal is a normal blood score, achieved through a balancing act of lifestyle and medication. "Eventually most patients will follow a course of lifestyle, medications, then insulin," said Dr. Enrico Cagliero, referring to people diagnosed with the most common form of diabetes, known as Type 2. He's an endocrinologist at Massachusetts General Hospital and associate professor of medicine at Harvard Medical School.
CALIFORNIA | LOCAL
September 24, 1986 |
In the first trial studies of their kind in the United States, diabetes specialists from UC Irvine and Johns Hopkins University have been given approval by the U.S. Food and Drug Administration to surgically implant insulin pumps, UCI officials said Tuesday.